Dr. Reddys Laboratories Ltd.

Further to its intimation dated May 17, 2024, on the inspection conducted by the United States Food & Drug Administration (USFDA) at its formulations manufacturing facilities (FTO-7 & FTO-9) in Duvvada, Visakhapatnam, Dr. Reddy’s Laboratories has informed that the Company has received the Establishment Inspection Report (EIR). The USFDA has classified the inspection as Voluntary Action Indicated (VAI) and concluded that the inspection is ‘closed’ under 21 CFR 20.64(d)(3).

The above information is a part of company’s filings submitted to BSE.